首页> 外文期刊>Breast cancer research and treatment >SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER plus breast cancer: genome-wide association studies of the estrone pathway
【24h】

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER plus breast cancer: genome-wide association studies of the estrone pathway

机译:SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER plus breast cancer: genome-wide association studies of the estrone pathway

获取原文
获取原文并翻译 | 示例
           

摘要

Background Estrone (E1), the major circulating estrogen in postmenopausal women, promotes estrogen-receptor positive (ER+) breast tumor growth and proliferation. Two major reactions contribute to E1 plasma concentrations, aromatase (CYP19A1) catalyzed E1 synthesis from androstenedione and steroid sulfatase (STS) catalyzed hydrolysis of estrone conjugates (E1Cs). E1Cs have been associated with breast cancer risk and may contribute to tumor progression since STS is expressed in breast cancer where its activity exceeds that of aromatase.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号